Skip to Content
Merck
  • Improved positron emission tomography imaging of glioblastoma cancer using novel

Improved positron emission tomography imaging of glioblastoma cancer using novel

Amino acids (2017-03-21)
Mathias Dyrberg Loft, Yao Sun, Changhao Liu, Camilla Christensen, Daijuan Huang, Andreas Kjaer, Zhen Cheng
ABSTRACT

The urokinase-type plasminogen activator receptor (uPAR) is overexpressed in several cancers including glioblastoma (GBM) and is an established biomarker for metastatic potential. The uPAR-targeting peptide AE105-NH